MRA Advisory Group
ABBV icon

MRA Advisory Group’s AbbVie ABBV Stock Holding History

MRA Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$582K Sell
2,224
-5,659
-72% -$1.45M 0.22% 68
2026
Q2 		$1.98M Buy
7,883
+5,215
+195% +$1.12M 0.72% 30
2026
Q1 		$580K Sell
2,668
-20
-0.7% -$4.44K 0.24% 62
2025
Q4 		$614K Sell
2,688
-201
-7% -$45.8K 0.26% 58
2025
Q3 		$669K Sell
2,889
-1
-0% -$204 0.29% 49
2025
Q2 		$536K Sell
2,890
-549
-16% -$102K 0.25% 63
2025
Q1 		$721K Buy
3,439
+292
+9% +$56.8K 0.38% 34
2024
Q4 		$559K Buy
3,147
+155
+5% +$28.5K 0.3% 42
2024
Q3 		$591K Buy
2,992
+16
+0.5% +$2.99K 0.32% 40
2024
Q2 		$510K Buy
2,976
+383
+15% +$63.4K 0.29% 45
2024
Q1 		$472K Buy
2,593
+654
+34% +$113K 0.28% 50
2023
Q4 		$300K Sell
1,939
-741
-28% -$108K 0.2% 65
2023
Q3 		$400K Sell
2,680
-559
-17% -$82.1K 0.29% 68
2023
Q2 		$436K Buy
3,239
+226
+8% +$33.1K 0.3% 56
2023
Q1 		$480K Buy
3,013
+615
+26% +$94K 0.35% 53
2022
Q4 		$388K Sell
2,398
-205
-8% -$31.4K 0.3% 67
2022
Q3 		$360K Sell
2,603
-143
-5% -$20.5K 0.31% 69
2022
Q2 		$421K Buy
2,746
+140
+5% +$21.4K 0.37% 62
2022
Q1 		$422K Buy
2,606
+23
+0.9% +$3.34K 0.32% 64
2021
Q4 		$350K Sell
2,583
-3,692
-59% -$436K 0.27% 71
2021
Q3 		$677K Buy
6,275
+383
+7% +$43.8K 0.58% 41
2021
Q2 		$664K Sell
5,892
-334
-5% -$37.6K 0.57% 40
2021
Q1 		$674K Buy
6,226
+175
+3% +$18.7K 0.63% 38
2020
Q4 		$648K Buy
+6,051
New +$581K 0.64% 38

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

MRA Advisory Group's ABBV Position: Q3 2026 in Review

MRA Advisory Group reduced its AbbVie (ABBV) stake by 72% in Q3 2026, selling an estimated $1.45M and leaving 2,224 shares worth $582K. The position accounts for 0.22% of the portfolio, ranked #68.

MRA Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.98M in Q2 2026. 3,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • MRA Advisory Group held 2,224 shares of AbbVie worth $582K as of Q3 2026.
  • MRA Advisory Group sold 5,659 AbbVie shares in Q3 2026, an estimated $1.45M.
  • AbbVie made up 0.22% of MRA Advisory Group's portfolio in Q3 2026, its #68 holding.
  • MRA Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • MRA Advisory Group's AbbVie position peaked at $1.98M in Q2 2026.
  • 3,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MRA Advisory Group's 13F filing for Q3 2026, filed 7 Oct 2026.